Clinical Trial Update: GP Plus Adebrelimab Versus GP Neoadjuvant Chemotherapy for Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing GP plus adebrelimab versus GP neoadjuvant chemotherapy for nasopharyngeal carcinoma is currently recruiting. The study assesses…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Adebrelimab (adebrelimab)
• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Carcinoma | Phase 2 | Status: RECRUITING